Cilostamide, phosphodiesterase inhibitor

Code: c7971-5mg D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

PDE3 catalyzes the phosphodiester bond hydrolysis, observed in secondory messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine...


read more

Your Price
£274.00 5MG
REQUEST

Not available outside of the UK & Ireland.

Biochem/physiol Actions

PDE3 catalyzes the phosphodiester bond hydrolysis, observed in secondory messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Inhibitors of PDE3 are generally inotropic and vasodilatory. They are being recognized for its use in treating heart failures. Cilostamide is known to delay meiotic progression.

Selective inhibitor of PDE3 (cGMP-inhibited phosphodiesterase); IC50 = 70 ± 9 nM. This inhibitory effect increases intracellular cAMP and inhibits platelet aggregation.

assay≥97% (HPLC)
formpowder
Gene Informationhuman ... PDE3A(5139), PDE3B(5140), PDE5A(8654), PDE7A(5150)rat ... Pde2a(81743), Pde4a(25638)
InChI keyUIAYVIIHMORPSJ-UHFFFAOYSA-N
InChI1S/C20H26N2O3/c1-22(16-6-3-2-4-7-16)20(24)8-5-13-25-17-10-11-18-15(14-17)9-12-19(23)21-18/h9-12,14,16H,2-8,13H2,1H3,(H,21,23)
Quality Level100
SMILES stringCN(C1CCCCC1)C(=O)CCCOc2ccc3NC(=O)C=Cc3c2
solubilityDMSO: 20 mg/mL, clear, colorless to faintly yellow
Cas Number68550-75-4
This product has met the following criteria: